C4X Discovery is a drug discovery and development company focused on creating next-generation small molecule medicines for immuno-inflammatory diseases. It combines scientific expertise with proprietary technologies to identify, design and advance differentiated drug candidates. Its platforms include Conformetrix®, which supports accelerated structural drug design, and PatientSeek, a precision medicine tool for genetics-led patient stratification. The company develops an internal portfolio of discovery programmes and partners selected assets with pharmaceutical companies for later-stage development and commercialisation. Its industry is biotechnology and pharmaceutical research, with a focus on improving how targeted oral therapies are discovered and brought closer to clinical use.
